CTBP2P1

Across TCGA pan-cancer cohorts, CTBP2P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated CTBP2P1 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CTBP2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CTBP2P1 expression acts as an unfavorable survival marker, although some lineages such as TGCT and OV show a favorable association.

COAD, THCA, and LIHC are the cancer types where CTBP2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	II,III,IV	0.039	0.851	<.001	105	view →
THCA	DFS	Tertile	II,III,IV	0.287	0.708	<.001	63	view →
LIHC	OS	Tertile	All	0.309	0.542	<.001	45	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
KICH	DFS	Tertile	All	0.610	0.968	.010	33	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	18	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	18	view →
ESCA	OS	Tertile	All	0.438	0.589	.030	15	view →
LUAD	DFS	Tertile	IV	0.671	0.893	.019	15	view →
LGG	DFS	Tertile	All	0.217	0.407	.027	12	view →
STAD	OS	Tertile	IV	0.174	0.463	.012	9	view →
TGCT	DFS	Tertile	All	1.000	0.806	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

CTBP2P1–COAD (OS)

Open the COAD breakdown →